vs
Side-by-side financial comparison of Albemarle Corporation (ALB) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
Albemarle Corporation is the larger business by last-quarter revenue ($1.4B vs $1.4B, roughly 1.0× SELECT MEDICAL HOLDINGS CORP). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 4.5% vs -29.0%, a 33.5% gap on every dollar of revenue. On growth, Albemarle Corporation posted the faster year-over-year revenue change (15.9% vs 5.0%). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (5.3% CAGR vs 2.4%).
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers...
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
ALB vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.4B |
| Net Profit | $-414.2M | $63.8M |
| Gross Margin | 13.9% | — |
| Operating Margin | -15.2% | 6.9% |
| Net Margin | -29.0% | 4.5% |
| Revenue YoY | 15.9% | 5.0% |
| Net Profit YoY | -650.1% | -14.7% |
| EPS (diluted) | $-3.88 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.4B | $1.4B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $1.4B | $1.3B | ||
| Q2 24 | $1.4B | $1.3B |
| Q1 26 | — | $63.8M | ||
| Q4 25 | $-414.2M | $20.2M | ||
| Q3 25 | $-160.7M | $28.8M | ||
| Q2 25 | $22.9M | $40.6M | ||
| Q1 25 | $41.3M | $56.7M | ||
| Q4 24 | $75.3M | $-16.1M | ||
| Q3 24 | $-1.1B | $55.6M | ||
| Q2 24 | $-188.2M | $77.6M |
| Q1 26 | — | — | ||
| Q4 25 | 13.9% | — | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | 14.8% | — | ||
| Q1 25 | 14.5% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | -7.7% | — | ||
| Q2 24 | -0.7% | — |
| Q1 26 | — | 6.9% | ||
| Q4 25 | -15.2% | 4.6% | ||
| Q3 25 | -16.6% | 5.4% | ||
| Q2 25 | 3.6% | 6.5% | ||
| Q1 25 | 1.8% | 8.3% | ||
| Q4 24 | 0.4% | 1.6% | ||
| Q3 24 | -81.9% | 4.3% | ||
| Q2 24 | -34.4% | 5.8% |
| Q1 26 | — | 4.5% | ||
| Q4 25 | -29.0% | 1.4% | ||
| Q3 25 | -12.3% | 2.1% | ||
| Q2 25 | 1.7% | 3.0% | ||
| Q1 25 | 3.8% | 4.2% | ||
| Q4 24 | 6.1% | -1.2% | ||
| Q3 24 | -78.9% | 4.4% | ||
| Q2 24 | -13.2% | 6.1% |
| Q1 26 | — | $0.35 | ||
| Q4 25 | $-3.88 | $0.17 | ||
| Q3 25 | $-1.72 | $0.23 | ||
| Q2 25 | $-0.16 | $0.32 | ||
| Q1 25 | $0.00 | $0.44 | ||
| Q4 24 | $0.29 | $-0.12 | ||
| Q3 24 | $-9.45 | $0.43 | ||
| Q2 24 | $-1.96 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $25.7M |
| Total DebtLower is stronger | $3.2B | $1.8B |
| Stockholders' EquityBook value | $9.5B | $2.1B |
| Total Assets | $16.4B | $6.0B |
| Debt / EquityLower = less leverage | 0.33× | 0.88× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $25.7M | ||
| Q4 25 | — | $26.5M | ||
| Q3 25 | $1.9B | $60.1M | ||
| Q2 25 | $1.8B | $52.3M | ||
| Q1 25 | $1.5B | $53.2M | ||
| Q4 24 | $1.2B | $59.7M | ||
| Q3 24 | $1.7B | $191.5M | ||
| Q2 24 | $1.8B | $111.2M |
| Q1 26 | — | $1.8B | ||
| Q4 25 | $3.2B | $1.8B | ||
| Q3 25 | $3.6B | $1.7B | ||
| Q2 25 | $3.6B | $1.8B | ||
| Q1 25 | $3.5B | $1.8B | ||
| Q4 24 | $3.5B | $1.7B | ||
| Q3 24 | $3.6B | $3.1B | ||
| Q2 24 | $3.5B | $3.6B |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $9.5B | $1.7B | ||
| Q3 25 | $10.0B | $1.7B | ||
| Q2 25 | $10.2B | $1.7B | ||
| Q1 25 | $10.0B | $1.7B | ||
| Q4 24 | $10.0B | $1.7B | ||
| Q3 24 | $10.2B | $1.9B | ||
| Q2 24 | $11.2B | $1.4B |
| Q1 26 | — | $6.0B | ||
| Q4 25 | $16.4B | $5.9B | ||
| Q3 25 | $17.1B | $5.7B | ||
| Q2 25 | $17.3B | $5.7B | ||
| Q1 25 | $17.0B | $5.7B | ||
| Q4 24 | $16.6B | $5.6B | ||
| Q3 24 | $17.5B | $8.0B | ||
| Q2 24 | $18.4B | $7.9B |
| Q1 26 | — | 0.88× | ||
| Q4 25 | 0.33× | 1.06× | ||
| Q3 25 | 0.36× | 1.03× | ||
| Q2 25 | 0.35× | 1.10× | ||
| Q1 25 | 0.35× | 1.03× | ||
| Q4 24 | 0.35× | 1.01× | ||
| Q3 24 | 0.35× | 1.62× | ||
| Q2 24 | 0.31× | 2.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $388.5M | — |
| Free Cash FlowOCF − Capex | $233.1M | — |
| FCF MarginFCF / Revenue | 16.3% | — |
| Capex IntensityCapex / Revenue | 10.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $692.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $388.5M | $64.3M | ||
| Q3 25 | $355.6M | $175.3M | ||
| Q2 25 | $-7.2M | $110.3M | ||
| Q1 25 | $545.4M | $-3.5M | ||
| Q4 24 | $674.0K | $125.4M | ||
| Q3 24 | $240.5M | $181.0M | ||
| Q2 24 | $362.9M | $278.2M |
| Q1 26 | — | — | ||
| Q4 25 | $233.1M | $5.2M | ||
| Q3 25 | $223.4M | $122.2M | ||
| Q2 25 | $-126.8M | $45.6M | ||
| Q1 25 | $362.8M | $-55.8M | ||
| Q4 24 | $-355.1M | $62.0M | ||
| Q3 24 | $-62.6M | $130.3M | ||
| Q2 24 | $-84.7M | $222.6M |
| Q1 26 | — | — | ||
| Q4 25 | 16.3% | 0.4% | ||
| Q3 25 | 17.1% | 9.0% | ||
| Q2 25 | -9.5% | 3.4% | ||
| Q1 25 | 33.7% | -4.1% | ||
| Q4 24 | -28.8% | 4.7% | ||
| Q3 24 | -4.6% | 10.2% | ||
| Q2 24 | -5.9% | 17.4% |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | 4.2% | ||
| Q3 25 | 10.1% | 3.9% | ||
| Q2 25 | 9.0% | 4.8% | ||
| Q1 25 | 17.0% | 3.9% | ||
| Q4 24 | 28.9% | 4.8% | ||
| Q3 24 | 22.4% | 4.0% | ||
| Q2 24 | 31.3% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.19× | ||
| Q3 25 | — | 6.09× | ||
| Q2 25 | -0.31× | 2.72× | ||
| Q1 25 | 13.19× | -0.06× | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALB
| Energy Storage | $759.1M | 53% |
| Specialties | $348.9M | 24% |
| Ketjen | $320.1M | 22% |
SEM
Segment breakdown not available.
